Financials in USD. Standardized financial statements.
A compact view of how Bioventus Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $568.09M | $573.28M | $512.35M | $512.12M | $430.90M | $321.16M | $340.14M | $319.18M | $292.06M | $274.50M |
| Revenue Growth? | -0.9% | +11.9% | +0.0% | +18.8% | +34.2% | -5.6% | +6.6% | +9.3% | +6.4% | 0.0% |
| Cost of Revenue? | $185.66M | $185.05M | $184.15M | $181.04M | $128.19M | $87.64M | $90.94M | $84.17M | $92.10M | $91.39M |
| Gross Profit? | $382.43M | $388.23M | $328.19M | $331.08M | $302.71M | $233.52M | $249.21M | $235.01M | $199.96M | $183.11M |
| Gross Margin? | +67.3% | +67.7% | +64.1% | +64.6% | +70.3% | +72.7% | +73.3% | +73.6% | +68.5% | +66.7% |
| Operating Expenses? | $323.88M | $400.20M | $409.92M | $498.31M | $290.64M | $212.28M | $218.01M | $209.50M | $172.94M | $168.22M |
| Operating Income? | $58.55M | -$11.98M | -$81.72M | -$167.23M | $12.06M | $21.24M | $31.19M | $25.50M | $27.02M | $14.89M |
| EBITDA? | $105.56M | $39.22M | -$23.07M | -$121.61M | $45.48M | $54.31M | $61.58M | $54.52M | $59.85M | $44.05M |
| Income Before Tax | $25.71M | -$49.13M | -$121.11M | -$189.03M | $9.49M | $15.91M | $9.69M | $6.11M | $8.66M | -$5.65M |
| Income Tax Expense | -$1.56M | -$5.29M | $85,000 | -$44.37M | -$1.97M | $1.19M | $1.58M | $1.66M | -$785,000 | $1.09M |
| Net Income? | $22.73M | -$33.54M | -$156.23M | -$158.70M | $19.38M | $16.41M | $6.85M | -$12.21M | -$1.64M | -$17.95M |
| EPS? | $0.34 | $-0.52 | $-2.49 | $-2.59 | $-0.15 | $0.44 | $0.12 | $-0.22 | $-0.03 | $-0.32 |
| Diluted EPS? | $0.33 | $-0.52 | $-2.49 | $-2.59 | $-0.15 | $0.44 | $0.12 | $-0.22 | $-0.03 | $-0.32 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality